Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication

Gene Therapy
A CaputoP G Balboni

Abstract

A series of retroviral vectors with potential anti-tat and antirev activity was developed. Vectors containing a tat transdominant negative mutant (tat22/37) and an RRE decoy in different positions, directed by the same promoter or by different promoters, were generated. Retroviral vectors containing tat22/37 and the RevM10 transdominant negative mutant were also constructed. Jurkat cells were transduced with the recombinant retroviruses to produce monoclonal and polyclonal cultures. In these cell lines the recombinant proviruses were correctly integrated and expression of the inserted genes was detected by Northern blot or RT-PCR analysis. However, infection of these cell lines with HIV-1 showed that none of these recombinant constructs inhibited virus replication at a high multiplicity of infection (MOI). At a low MOI, two cell clones containing tat22/37 and the RRE decoy in 3' position showed a long lasting protection against virus replication, in comparison to control cultures expressing tat22/37 or RRE alone. Combination of tat and rev mutants was ineffective in inhibiting HIV-1 replication at both low and high MOIs. At a low MOI, HIV-1 replication was efficiently blocked in two cell clones expressing the RevM10 mutant alon...Continue Reading

Citations

Mar 19, 1999·Trends in Microbiology·J F van den HeuvelF van der Wilk
Apr 3, 2001·AIDS Research and Human Retroviruses·J BaiR Akkina
Feb 13, 2002·AIDS Patient Care and STDs·Mario R Mautino, Richard A Morgan
Apr 5, 2001·Sexually Transmitted Infections·A M Lever
Jun 25, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·A SavarinoP Gupta
Aug 29, 2003·Expert Opinion on Biological Therapy·Ananthalakshmi PoluriRichard E Sutton
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·J BaiR Akkina
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·David S StrayerJohn A Zaia
Jun 13, 2001·Oncogene·F MaciánA Rao
Jun 13, 2001·Oncogene·P K Vogt

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.